Li Ling
Impact in
- Cell Biology top 10%
- Hippo pathway signaling and YAP/TAZ
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Epigenetics and DNA Methylation 2
- Cell death mechanisms and regulation 2
- Signaling Pathways in Disease 1
- Oncology 4
- Co-authors
- Fangfang Zhou (2 shared papers)Feng Chu (2 shared papers)Shuai Wang (2 shared papers)Suping Zhang (1 shared paper)Lili Zhou (1 shared paper)Zhengai Xiong (1 shared paper)Yaping Wang (1 shared paper)Lin Wang (1 shared paper)
- Journals
- Journal of Hypertension (1 paper)Frontiers in Cell and Developmental Biology (1 paper)Nature Communications (1 paper)Frontiers in Immunology (1 paper)Brain Research (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Li Ling
18 papers receiving 598 citations
Peers
Comparison fields: 5 of 83
- Cell Biology 189
- Cancer Research 81
- Immunology 109
- Aging 8
- Reproductive Medicine 36
Countries citing papers authored by Li Ling
This map shows the geographic impact of Li Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Ling more than expected).
Fields of papers citing papers by Li Ling
This network shows the impact of papers produced by Li Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Ling. The network helps show where Li Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 156 | |
| 2 | 2020 | 106 | |
| 3 | 2021 | 67 | |
| 4 | 2017 | 61 | |
| 5 | 2018 | 59 | |
| 6 | 2018 | 41 | |
| 7 | 2008 | 38 | |
| 8 | 2018 | 17 | |
| 9 | 2020 | 15 | |
| 10 | 2019 | 11 | |
| 11 | 2023 | 11 | |
| 12 | 2020 | 8 | |
| 13 | 2014 | 5 | |
| 14 | 2000 | 4 | |
| 15 | 2023 | 3 | |
| 16 | 2022 | 2 | |
| 17 | 2023 | 2 | |
| 18 | 2025 | 1 | |
| 19 | 2024 | 0 |
About Li Ling
Li Ling is a scholar working on Molecular Biology, Oncology, Rheumatology, Cell Biology and Immunology, having authored 19 papers that have together received 607 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (2 papers), Cancer-related molecular mechanisms research (2 papers), Head and Neck Cancer Studies (2 papers), interferon and immune responses (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Cell death mechanisms and regulation (2 papers), Ovarian function and disorders (1 paper) and Signaling Pathways in Disease (1 paper). The work is most often cited by research in Cell Biology (189 citations), Cancer Research (81 citations), Immunology (109 citations), Aging (8 citations) and Reproductive Medicine (36 citations). Li Ling has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Fangfang Zhou, Feng Chu, Shuai Wang, Suping Zhang, Lili Zhou, Zhengai Xiong, Yaping Wang, Lin Wang, Hans van Dam and Bing Yang. Their work appears in journals such as Journal of Hypertension, Frontiers in Cell and Developmental Biology, Nature Communications, Frontiers in Immunology and Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.